TP53 and acute myeloid leukemia: categorized 98 de novo AML cases using similar cut-offs: VAF >40%, VAF 20% - 40% and VAF <20%; sub-clonal TP53 mutation (VAF <20%) showed a negative prognostic effect in terms of CR rate, OS and EFS (81).